InsiderTrades

Form 4 for NOC Northrop Grumman

Accepted 2025-02-20 00:00:00 ET · period of report 2025-02-18 · accession 0001628280-25-006856 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-02-20 2025-02-18 NOC Davies Benjamin R. CVP, Pres. Defense Systems M - OptEx $0.00 +976.80 1,294 +308% $0
DM 2025-02-20 2025-02-18 NOC Davies Benjamin R. CVP, Pres. Defense Systems F - Tax $441.36 -320 1,194 -21% -$141.2K
D 2025-02-20 2025-02-18 NOC Davies Benjamin R. CVP, Pres. Defense Systems S - Sale+OE $445.35 -293 900.72 -25% -$130.5K
DM 2025-02-20 2025-02-18 NOC Davies Benjamin R. CVP, Pres. Defense Systems M - OptEx $0.00 -976.80 5,017 -16% $0
DM 2025-02-20 2025-02-18 NOC Davies Benjamin R. CVP, Pres. Defense Systems A - Grant $0.00 +7,856 11.9K +193% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-02-18 M A 684.80 $0.00 1,221.72 D — —
2 Common Common Stock 2025-02-18 F D 220 $441.36 1,001.72 D — —
3 Common Common Stock 2025-02-18 M A 292 $0.00 1,293.72 D — —
4 Common Common Stock 2025-02-18 F D 100 $441.36 1,193.72 D — —
5 Common Common Stock 2025-02-18 S D 293 $445.35 900.72 D — — (F1) The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2024.
6 Derivative Restricted Performance Stock Rights 2025-02-18 M D 684.80 $0.00 11,240 D — · — to — 684.80 Common Stock (F9) Total amount includes (i) 639 RSRs granted under the 2011 LTISP on 2/16/23 with a measurement period ending on 12/31/25; (ii) 1,495 RPSRs granted under the 2011 LTISP on 11/1/23 with a measurement period ending on 12/31/25; (iii) 2,352 RPSRs granted under the 2011 LTISP on 2/14/24 with a measurement period ending on 12/31/26; (iv) 1,399 RPSRs granted under the 2024 LTISP on 7/31/24 with a measurement period ending on 12/31/26; and (v) 5,355 RPSRs granted under the 2024 LTISP on 2/18/25 with a measurement period ending on 12/31/27. (F3) Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).
7 Derivative Restricted Stock Rights 2025-02-18 A A 2,456 $0.00 5,309 D — · — to — 2,456 Common Stock (F8) Total amount includes (i) 292 RSRs granted under the 2011 LTISP on 2/15/22 that vested on 2/18/25; (ii) 274 RSRs granted under the 2011 LTISP on 2/16/23 that will vest on 2/17/26; (iii) 641 RSRs granted under the 2011 LTISP on 11/1/23 that will vest on 11/2/26; (iv) 1,008 RSRs granted under the 2011 LTISP on 2/14/24 that will vest on 2/16/27; (v) 638 RSRs granted under the 2024 LTISP on 7/31/24 that will vest on 8/2/27; and (vi) 2,456 RSRs granted under the 2024 LTISP on 2/18/25 that will vest on 2/18/28. (F6) Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. (F7) The RSRs were granted under the 2024 LTISP on 2/18/2025 and will vest on 2/18/2028.
8 Derivative Restricted Performance Stock Rights 2025-02-18 A A 5,399.80 $0.00 11,924.80 D — · — to — 5,399.80 Common Stock (F4) The RPSRs acquired include (i) 44.80 vested RPSRs with respect to the measurement period ended 12/31/24 acquired due to settlement of the RPSRs granted under the 2011 Long-Term Incentive Stock Plan ("2011 LTISP") on 2/15/22 that resulted in settlement at 107% of the target award; and (ii) 5,355 unvested RPSRs granted under the 2024 Long-Term Incentive Stock Plan (the "2024 LTISP") on 2/18/25 with a measurement period ending on 12/31/27. A total of 684.80 shares were issued in settlement of the 2022 RPSRs with a measurement period that ended 12/31/24, and the target award amount of 640 RPSRs was previously reported in connection with the grant of the 2022 RPSRs. (F5) Total amount includes (i) 684.80 vested RPSRs granted under the 2011 LTISP on 2/15/22 with a measurement period ended on 12/31/24; (ii) 639 RPSRs granted under the 2011 LTISP on 2/16/23 with a measurement period ending on 12/31/25; (iii) 1,495 RPSRs granted under the 2011 LTISP on 11/1/23 with a measurement period ending on 12/31/25; (iv) 2,352 RPSRs granted under the 2011 LTISP on 2/14/24 with a measurement period ending on 12/31/26; (v) 1,399 RPSRs granted under the 2024 LTISP on 7/31/24 with a measurement period ending 12/31/26; and (vi) 5,355 RPSRs granted under the 2024 LTISP on 2/18/25 with a measurement period ending on 12/31/27. (F3) Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).
9 Derivative Restricted Stock Rights 2025-02-18 M D 292 $0.00 5,017 D — · — to — 292 Common Stock (F6) Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. (F10) Shares issued upon vesting of RSRs granted under the 2011 LTISP on 2/15/22 that vested on 2/18/25.